Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Filtered Interaction Map red green network_comparison
Results: HTML CSV LaTeX
Showing element 425 to 474 of 502 in total
Value Type: Ranked
Network Comparison Type: Divided
Filtered: 0
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCRIB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
scribble. [source:refseq;acc:nm\_015356]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12370.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12719\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02817\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
426\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 70 kda subunit (lupus ku autoantigen protein p70) (ku70) (70 kda subunit of ku antigen) (thyroid-lupus autoantigen) (tlaa) (ctc box binding factor 75 kda subunit) (ctcbf) (ctc75). [source:swissprot;acc:p12956]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9412.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9676.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02805\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
427\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11276.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11582.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02719\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
428\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSTF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cleavage stimulation factor, 64 kda subunit (cstf 64 kda subunit) (cf-1 64 kda subunit). [source:swissprot;acc:p33240]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11982.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12301.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02658\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
429\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l14 (cag-isl 7). [source:swissprot;acc:p50914]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12318.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12631.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02539\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
430\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
splicing factor 3b subunit 3 (spliceosome associated protein 130) (sap 130) (sf3b130) (pre-mrna splicing factor sf3b 130 kda subunit). [source:swissprot;acc:q15393]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11621.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11913.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0251\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
431\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
histone deacetylase 2 (hd2). [source:swissprot;acc:q92769]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10043.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9799.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02495\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
432\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FBN3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fibrillin 3. [source:refseq;acc:nm\_032447]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
930\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
953\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02473\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
433\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
trinucleotide repeat containing 15. [source:refseq;acc:nm\_015575]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
772\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
754\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02387\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
434\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 3 (hu-antigen c) (huc) (paraneoplastic cerebellar degeneration-associated antigen) (paraneoplastic limbic encephalitis antigen 21). [source:swissprot;acc:q14576]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10028.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10261.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02323\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIST2H2BA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.q (h2b/q) (h2b-gl105). [source:swissprot;acc:q16778]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8770.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8574.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02296\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
436\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.d (h2b/d). [source:swissprot;acc:q99877]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8770.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8574.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02293\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
437\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.s (h2b/s). [source:swissprot;acc:p57053]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8770.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8574.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02283\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
438\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
histone h3.1 (h3/a) (h3/c) (h3/d) (h3/f) (h3/h) (h3/i) (h3/j) (h3/k) (h3/l). [source:swissprot;acc:p16106]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7759.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7586.42\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0228\vspace{3pt}}}\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
439\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b. [source:refseq;acc:nm\_175055]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8770.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8574.79\vspace{3pt}}&\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
440\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.e (h2b/e). [source:swissprot;acc:q99879]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8770.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8574.81\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIST1H2BL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.c (h2b/c). [source:swissprot;acc:q99880]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8770.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8574.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02276\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
442\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
huntingtin-interacting protein hypa/fbp11 (fragment). [source:sptrembl;acc:o75404]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14570.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14247.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02268\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
443\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9141.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8940.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02253\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
444\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
formin binding protein 3; fas-ligand associated factor 1; huntingtin-interacting protein a; ny-ren-6 antigen. [source:refseq;acc:nm\_017892]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14556.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14237.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0224\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
445\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
histone h3.3 (h3.a) (h3.b) (h3.3q). [source:swissprot;acc:p06351]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7965.06\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7790.78\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02237\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
446\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
dj1099d15.1 (putative dnaj protein). [source:sptrembl;acc:q9h4j9]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHMP4A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein hspc134 (protein cda04). [source:swissprot;acc:q9by43]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12532.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12808.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02207\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
448\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C19orf56\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-140 (protein ptd008) (my006 protein). [source:swissprot;acc:q9y284]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2939\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2876\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02191\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
449\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARPC1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arp2/3 complex 41 kda subunit (p41-arc) (actin-related protein 2/3 complex subunit 1b). [source:swissprot;acc:o15143]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9897.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9690.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02129\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
450\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11290.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11525.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02081\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
451\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cell adhesion molecule with homology to l1cam precursor; neural cell adhesion molecule; cell adhesion molecule l1-like; l1 cell adhesion molecule 2. [source:refseq;acc:nm\_006614]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
14010.2\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
13737.2\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01987\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
452\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neural cell adhesion molecule l1 precursor (n-cam l1) (cd171 antigen). [source:swissprot;acc:p32004]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
453\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TAF9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription initiation factor tfiid 31 kda subunit (tafii-31) (tafii-32) (tafii32). [source:swissprot;acc:q16594]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
454\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LATS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lats homolog 1. [source:refseq;acc:nm\_004690]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
13933.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
14204.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01947\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
455\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh3 domain-binding glutamic acid-rich-like protein 2 (fovea-associated sh3 domain binding protein). [source:swissprot;acc:q9ujc5]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
456\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
williams-beuren syndrome critical region protein 20 copy b. [source:refseq;acc:nm\_145645]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
16416.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
16721.6\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01861\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
457\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NSUN5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
williams beuren syndrome critical region 20a isoform 2; nol1/nop2/sun gene family member; williams-beuren syndrome critical region protein 20 copy a; williams beuren syndrome chromosome region 20. [source:refseq;acc:nm\_018044]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
458\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NSUN5B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
williams beuren syndrome chromosome region 20c isoform 1. [source:refseq;acc:nm\_032158]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
459\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TSNAX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
translin-associated protein x (translin-associated factor x). [source:swissprot;acc:q99598]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20875\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20495\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01854\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
460\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s6 (mrp-s6). [source:swissprot;acc:p82932]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20914\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20558\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01732\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
461\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
scratch; scratch 1. [source:refseq;acc:nm\_031309]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12164.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12358.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01588\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
462\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
dj850e9.1 (novel c2h2 type zinc finger protein similar to drosophila scratch (scrt), slug and xenopus snail) (fragment). [source:sptrembl;acc:q9nq03]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12189.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12378.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01548\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
463\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
dj153g14.2 (possible ca binding protein similar to nefa) (fragment). [source:sptrembl;acc:q9ujn8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5558.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5473.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01536\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
464\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
ba395l14.12 (novel protein similar to small nuclear ribonucleoprotein polypeptide a' (snrpa1)). [source:sptrembl;acc:q9nu36]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10076.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9928.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01494\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
465\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
transducin-like enhancer protein 1 (esg1). [source:swissprot;acc:q04724]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9482.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9620.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01455\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
466\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1543\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1521\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01446\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
467\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2a.c/d/i/n/p (h2a.1) (h2a/c) (h2a/d) (h2a/i) (h2a/n) (h2a/p) (h2a.1b). [source:swissprot;acc:p02261]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
21205\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
20914\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01391\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
468\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIST3H2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2a.a (h2a/a) (h2a.2). [source:swissprot;acc:p28001]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
469\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIST1H2AA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2a; h2a histone family, member r. [source:refseq;acc:nm\_170745]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
470\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
H2AFJ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
h2a histone family, member j isoform 1. [source:refseq;acc:nm\_018267]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
471\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LGALS4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
galectin-4 (lactose-binding lectin 4) (l-36 lactose binding protein) (l36lbp) (antigen ny-co-27). [source:swissprot;acc:p56470]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11319.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11463\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0127\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
472\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACOT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peroxisomal acyl-coenzyme a thioester hydrolase 2a (ec 3.1.2.2) (peroxisomal long-chain acyl-coa thioesterase 2) (zap128). [source:swissprot;acc:p49753]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7080.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7165.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01205\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
473\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GPS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cop9 signalosome complex subunit 1 (g protein pathway suppressor 1) (gps1 protein) (mfh protein). [source:swissprot;acc:q13098]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
816\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
825\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01103\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
474\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LMBR1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lipocalin-interacting membrane receptor. [source:refseq;acc:nm\_018113]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11290.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11167.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01097\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/